Stabilization versus inhibition of TAFIa by competitive inhibitors in vitro (Q44365963)

2 December 2017

Stabilization versus inhibition of TAFIa by competitive inhibitors in vitro (English)

1 reference

2 December 2017

John B Walker

1

1 reference

2 December 2017

Bernadette Hughes

2

1 reference

2 December 2017

Ian James

3

1 reference

2 December 2017

Peter Haddock

4

1 reference

2 December 2017

Cornelis Kluft

5

1 reference

2 December 2017

Laszlo Bajzar

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Journal of Biological Chemistry

2 December 2017

1 reference

2 December 2017

278

1 reference

2 December 2017

11

1 reference

2 December 2017

8913-8921

1 reference

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

2 December 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

A kinetic analysis of the tissue plasminogen activator and DSPAalpha1 cofactor activities of untreated and TAFIa-treated soluble fibrin degradation products of varying size

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

Enkephalin convertase: potent, selective, and irreversible inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

Purification and characterization of a new arginine carboxypeptidase in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

A simple method for the preparation of homogeneous phospholipid vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

Activation and characterization of procarboxypeptidase B from human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

Plasmin-mediated activation and inactivation of thrombin-activatable fibrinolysis inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

Role of zinc ions in activation and inactivation of thrombin-activatable fibrinolysis inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

Refined crystal structure of the potato inhibitor complex of carboxypeptidase A at 2.5 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

The crystal structure of the inhibitor-complexed carboxypeptidase D domain II and the modeling of regulatory carboxypeptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

Crystal structure of avian carboxypeptidase D domain II: a prototype for the regulatory metallocarboxypeptidase subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205006200

21 January 2018

Identifiers

DOI

10.1074/JBC.M205006200

1 reference

2 December 2017

1 reference